Application
18045129 · METHOD OF IDENTIFYING TREATMENT RESPONSIVE NON-SMALL CELL LUNG CANCER USING ANAPLASTIC LYMPHOMA KINASE (ALK) AS A MARKER
Filed 2022-10-07 · Granted · Patent 12631641 (2026-05-19) The official file ↗The patent and its PDF ↗ · Art unit 1642 · Examiner Nelson B Moseley II Easy · CPC G01N 33/5752 · Ventana Medical Systems, Inc. · Roche RMS / Charney IP Law
Office actions
2
first was Non-final rejection
RCEs
1
no appeal
To first action
33.1 mo
to disposition 43.4 mo
Statutes raised
103 112 DP
2 actions read